StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / obsidiantx.com

Obsidian Therapeutics

Obsidian Therapeutics (obsidiantx.com): 4 changes recorded in its website history since August 2016. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. ComplianceBetween and

    Now states FDA-APPROVED compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    BeforeOur lead internal programs are focused on engineering TIL therapies that are more effective and safer for patients with solid tumors
    AfterUnlocking the Promise of Precision Cell and Gene Therapy

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. HeadlineBetween and
    BeforeAt Obsidian, we are pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable dise…
    AfterOur lead internal programs are focused on engineering TIL therapies that are more effective and safer for patients with solid tumors

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  4. ComplianceBetween and

    Now states FDA-APPROVED compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 28 August 2018

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

Obsidian is developing next-generation cell and gene therapies with pharmacologic operating systems

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. January 2023 – November 2026 · 5 captures · latest observed messagingUnlocking the Promise of Precision Cell Therapy

    Obsidian Therapeutics is using its proprietary cytoDRiVE® platform to harness the power of proteins to engineer precision medicines.

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 5 captures in this group
    • 13 January 2023 · Unlocking the Promise of Precision Cell and Gene Therapy archived page
    • 20 July 2024 · Unlocking the Promise of Precision Cell and Gene Therapy archived page
    • 22 July 2025 · Unlocking the Promise of Precision Cell and Gene Therapy archived page
    • 12 July 2026 · Unlocking the Promise of Precision Cell and Gene Therapy archived page
    • 6 November 2026 · Unlocking the Promise of Precision Cell Therapy current websiteHistorical capture not publicly available
  2. Seen January 2022 · 1 captureOur lead internal programs are focused on engineering TIL therapies that are more effective and safer for patients with solid tumors

    This wording observed 14 January 2022.

    archived page
  3. April 2020 – January 2021 · 2 capturesAt Obsidian, we are pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases

    This wording observed 21 January 2021.

    archived page
    Inspect 2 captures in this group
    • 8 April 2020 · At Obsidian, we are pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases archived page
    • 21 January 2021 · At Obsidian, we are pioneering controllable cell and gene therapies to deliver transformative outcomes for patients with intractable diseases archived page

Cite this record

StartupHistory, “Obsidian Therapeutics” company record, https://startuphistory.org/c/obsidiantx.com

Machine-readable: /c/obsidiantx.com.json. How changes are found: method.